Upstate Active Clinical Trials
Study Title:
Safety and Immunogenicity of Fluzone® Quadrivalent VaccineAdministered to Healthy Children 6 to < 36 Months of Age
What is the purpose of the study? (in Layman's terms, please describe the study)
The main purpose of conducting this research study is to see if a full dose (0.5-mL volume) of Fluzone Quadrivalent vaccine is as safe and offers as much protection against flu viruses as the half dose (0.25-mL volume) in children 6 through 35 months of age. Vaccine safety will be measured by watching for any possible reactions to the flu vaccine, including fever.Upstate Institutional Review Board (IRB) Number:
928058Study/Protocol ID:
Study GRC88Study Phase:
Phase IVPatient Age Group:
ChildrenPrincipal Investigator:
Leonard B WeinerWho can I contact for more information?
Name: Maureen J Butler
Phone: 315-464-9441
Email: [email protected]